Early initiation of antiretroviral therapy: debate over?

Lancet Infect Dis. 2016 Jul;16(7):769. doi: 10.1016/S1473-3099(16)30077-9.

Authors

Luis F Lopez-Cortes¹, Alicia Gutierrez-Valencia², Omar J Ben-Marzouk-Hidalgo²

Affiliations

¹ Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Calle Antonio Maura Montaner, 41013 Seville, Spain. Electronic address: [email protected].
² Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Calle Antonio Maura Montaner, 41013 Seville, Spain.

PMID: 27352744
DOI: 10.1016/S1473-3099(16)30077-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-HIV Agents*
Anti-Retroviral Agents
Antiretroviral Therapy, Highly Active*
CD4 Lymphocyte Count
HIV Infections
Humans

Substances

Anti-HIV Agents
Anti-Retroviral Agents